Estradiol exerts neuroprotective effects when administered after ischemic insult.

BACKGROUND AND PURPOSE 17beta-Estradiol (E2) has been reported to exert neuroprotective effects when administered before an ischemic insult. This study was designed to determine whether E2 treatment after ischemia exerts the same effects and, if so, how long this therapeutic window remains open, and whether the effects are related to changes in cerebral blood flow (CBF). METHODS Female Sprague-Dawley rats were subjected to permanent middle cerebral artery occlusion (MCAO). In protocol 1, E2 was administered (100 microg/kg IV followed immediately by subcutaneous implantation of crystalline E2 in a silicone elastomer tube) to ovariectomized females (OVX+E2) at 0.5 (n=8), 1 (n=6), 2 (n=7), 3 (n=6), or 4 (n=9) hours after MCAO. Intact (INT; n=6) and ovariectomized females (OVX; n=12) were subjected to MCAO and received vehicle instead of E2. Two days after MCAO the animals were killed, and ischemic lesion volume was determined by 2,3,5-triphenyltetrazolium chloride staining. In protocol 2, CBF was monitored before and at 1, 24, and 48 hours in a group of animals receiving E2 or vehicle 0.5 hour after ischemia induction (INT, n=6; OVX, n=8; OVX+E2, n=6). RESULTS Lesion volume was 20.9+/-2.2% and 21.8+/-1.2% in the INT and OVX groups, respectively. E2 was found to decrease lesion volume significantly when administered within 3 hours after MCAO. The lesion volumes were 6.3+/-0.5%, 10.3+/-2.1%, 11.8+/-1.8%, 13.5+/-1.6%, and 17.9+/-2.8% when E2 was administered at 0.5, 1, 2, 3, or 4 hours after MCAO, respectively. CBF decreased to 43.1+/-2.2% and 25.4+/-1.0% in the INT and OVX animals, respectively, at 5 minutes after MCAO. In comparison to OVX rats, CBF was not different at 1 hour after E2 administration but was increased significantly in the OVX+E2 group 1 and 2 days after E2 administration. CONCLUSIONS E2 exerts neuroprotective effects when administered after ischemia, with a therapeutic window in a permanent focal cerebral ischemia model of approximately 3 hours. This effect of estradiol was associated with no immediate change in blood flow but with a delayed increase in CBF.

[1]  B. Crain,et al.  17beta-estradiol reduces stroke injury in estrogen-deficient female animals. , 1999, Stroke.

[2]  C. Iadecola,et al.  Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats. , 1999, Stroke.

[3]  R. Karas,et al.  Rapid vasomotor effects of estrogen: men are part of the club. , 1998, Chest.

[4]  S. Finklestein,et al.  Estradiol Protects against Ischemic Injury , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  D. Pelligrino,et al.  Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase , 1998, Neuroreport.

[6]  D. Dorsa,et al.  Modulation of Bcl‐2 expression: a potential component of estrogen protection in NT2 neurons , 1998, Neuroreport.

[7]  J. Shi,et al.  A system for the brain-enhanced delivery of estradiol: an assessment of its potential for the treatment of Alzheimer's disease and stroke. , 1998, Die Pharmazie.

[8]  R. Traystman,et al.  Estrogen-mediated neuroprotection after experimental stroke in male rats. , 1998, Stroke.

[9]  A. Day,et al.  Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats , 1998, Brain Research.

[10]  O. Scremin,et al.  Effects of Ovariectomy on Cerebral Blood Flow of Rats , 1998, Neuroendocrinology.

[11]  A. Day,et al.  Effects of gender and estradiol treatment on focal brain ischemia , 1998, Brain Research.

[12]  J. Simpkins,et al.  Low concentrations of estradiol reduce β-amyloid (25–35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells , 1997, Brain Research.

[13]  Y Q Zhang,et al.  Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. , 1997, Journal of neurosurgery.

[14]  J. Simpkins,et al.  Effects of 17β-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats , 1997, Experimental Brain Research.

[15]  E. Krebs,et al.  Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. , 1997, Endocrinology.

[16]  R. Hruban,et al.  17β-Estradiol Inhibits Apoptosis of Endothelial Cells , 1997 .

[17]  D. Farb,et al.  17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors , 1997, Brain Research.

[18]  J. Simpkins,et al.  17α-Estradiol Exerts Neuroprotective Effects on SK-N-SH Cells , 1997, The Journal of Neuroscience.

[19]  J. Manson,et al.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. , 1996, The New England journal of medicine.

[20]  G. Rosano,et al.  Oestrogen as a calcium channel blocker. , 1996, European heart journal.

[21]  D. Dorsa,et al.  Estrogen protects primary cortical neurons from glutamate toxicity , 1996, Neuroscience Letters.

[22]  P. Ramwell,et al.  The vascular protective effects of estrogen , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  D. Surmeier,et al.  Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  J. J. Smith,et al.  Estrogen inhibits the response-to-injury in a mouse carotid artery model. , 1995, The Journal of clinical investigation.

[25]  Lobo Ra.  Estrogen replacement: the evolving role of alternative delivery systems. Introduction. , 1995 .

[26]  R. Traystman,et al.  Postischemic Cerebral Blood Flow Recovery in the Female: Effect of 17β-Estradiol , 1995 .

[27]  J. Simpkins,et al.  The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. , 1995, Endocrinology.

[28]  H. Schnaper,et al.  Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. , 1995, Circulation.

[29]  R. Karas,et al.  Estrogen and the blood vessel wall , 1994, Current opinion in cardiology.

[30]  P. Poole‐Wilson,et al.  Cardiovascular protection by oestrogen—a calcium antagonist effect? , 1993, The Lancet.

[31]  J. Bar,et al.  The Effect of Estrogen Replacement Therapy on Platelet Aggregation and Adenosine Triphosphate Release in Postmenopausal Women , 1993, Obstetrics and gynecology.

[32]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[33]  B. Henderson,et al.  Decreased Mortality in Users of Estrogen Replacement Therapy , 1991, Archives of internal medicine.

[34]  R. Lobo.  Cardiovascular implications of estrogen replacement therapy , 1990, Obstetrics and gynecology.

[35]  W. Utian.  Panel Discussion 1 , 1990 .

[36]  K. Kogure,et al.  Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. , 1989, Stroke.

[37]  K.,et al.  Chronological changes in sex steroid, gonadotropin and prolactin secretions in aging female rats displaying different reproductive states. , 1979, Biology of reproduction.

[38]  H. Goldman,et al.  Hormones and regional brain blood flow , 1976, Pharmacology Biochemistry and Behavior.

[39]  R. Traystman,et al.  Gender-linked brain injury in experimental stroke. , 1998, Stroke.

[40]  J. Shi,et al.  Effects of 17beta-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rats. , 1997, Experimental brain research.

[41]  R. Traystman,et al.  Postischemic cerebral blood flow recovery in the female: effect of 17 beta-estradiol. , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[42]  R. Lobo.  Estrogen replacement: the evolving role of alternative delivery systems. Introduction. , 1995, American journal of obstetrics and gynecology.

[43]  J. Futó,et al.  Estrogen withdrawal selectively increases serotonin reactivity in rabbit basilar artery. , 1994, Life sciences.

[44]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.